Sabine C. Linn

Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial

A. Tutt, A. Tutt, N. Orr, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

M. J. van de Vijver, S. Rodenhuis, M. Hauptmann, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status

P. V. van Diest, A. Broeks, P. Nederlof, 2024, BMC medicine.

Expression of drug resistance proteins in breast cancer, in relation to chemotherapy

G. Giaccone, S. Linn, H. Pinedo, 1997, International journal of cancer.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

R. Beijersbergen, K. Berns, A. González-Angulo, 2007, Cancer cell.

Risk-Adjusted Cancer Screening and Prevention (RiskAP): 1 Complementing Screening for Early Disease Detection by a Learning 2 Screening based on Risk factors 3

D. Eccles, P. Devilee, J. Balmaña, 2021 .